نتائج البحث - "Rod Junor"

1

Multimethod quantitative benefit-risk assessment of treatments for moderate-to-severe osteoarthritis

المؤلفون: Jonathan Mauer, Kristin Bullok, Stephen Watt, Ed Whalen, Leo Russo, Rod Junor, John Markman, Brett Hauber, Tommi Tervonen

المصدر: British journal of clinical pharmacology. 88(8)

مصطلحات موضوعية: Pharmacology, Celecoxib, Anti-Inflammatory Agents, Non-Steroidal, Osteoarthritis, Humans, Pharmacology (medical), Opioid-Related Disorders, Risk Assessment, Randomized Controlled Trials as Topic

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b24e0a7847dd8681317f2f557ac6334c
https://pubmed.ncbi.nlm.nih.gov/35277997

View record in OpenAIRE

2

Subcutaneous tanezumab for osteoarthritis: Is the early improvement in pain and function meaningful and sustained?

المؤلفون: Kenji Miki, Mark T. Brown, Rod Junor, Richard M. Langford, Takaharu Yamabe, Naoki Isogawa, Francis Berenbaum, Christine R. West, William Carey, Serge Perrot, Lars Viktrup, Kenneth M. Verburg, Francisco J. Blanco

المساهمون: HAL-SU, Gestionnaire, Service de rhumatologie [CHU Saint-Antoine], CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), St Bartholomew's Hospital, Physiopathologie et Pharmacologie Clinique de la Douleur (LPPD), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Institut National de la Santé et de la Recherche Médicale (INSERM), Graduate School of Medicine [Osaka], Osaka University [Osaka], Universidade da Coruña, Pfizer, Eli Lilly and Company [Indianapolis]

المصدر: European Journal of Pain
European Journal of Pain, Wiley, In press, ⟨10.1002/ejp.1764⟩
RUC. Repositorio da Universidade da Coruña
instname
European Journal of Pain (London, England)
RUC: Repositorio da Universidade da Coruña
Universidade da Coruña (UDC)

مصطلحات موضوعية: medicine.medical_specialty, WOMAC, Efficacy, Tanezumab, Pain, Phases of clinical research, Osteoarthritis, Physical function, Antibodies, Monoclonal, Humanized, Placebo, Osteoarthritis, Hip, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Nerve growth factor, Double-Blind Method, Japan, medicine, Humans, 030212 general & internal medicine, Pain Measurement, [SDV.MHEP.RSOA] Life Sciences [q-bio]/Human health and pathology/Rhumatology and musculoskeletal system, business.industry, Original Articles, Osteoarthritis, Knee, medicine.disease, Treatment period, 3. Good health, Europe, Treatment Outcome, Anesthesiology and Pain Medicine, chemistry, [SDV.MHEP.RSOA]Life Sciences [q-bio]/Human health and pathology/Rhumatology and musculoskeletal system, Joint pain, [SDV.SP.PHARMA] Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology, Physical therapy, [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology, Original Article, medicine.symptom, business, 030217 neurology & neurosurgery

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b093ae274c1acea7291d5fdd1f1c3b01
https://hal.sorbonne-universite.fr/hal-03230696

View record in OpenAIRE

3

O06 Improvements in pain, function and health status with subcutaneous tanezumab compared with placebo in patients with OA: pooled analysis of two randomized controlled trials

المؤلفون: Stefan Wilhelm, David A. Walsh, Rod Junor, Francis Berenbaum, Thomas J. Schnitzer, Samantha Howland

المصدر: Rheumatology. 59

مصطلحات موضوعية: medicine.medical_specialty, Randomization, business.industry, Tanezumab, Mixed anxiety-depressive disorder, Osteoarthritis, Placebo, medicine.disease, Rheumatology, law.invention, chemistry.chemical_compound, Clinical research, Randomized controlled trial, chemistry, law, Internal medicine, medicine, Pharmacology (medical), business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::7904226d1b95c94dec0d3568bf4893d4
https://doi.org/10.1093/rheumatology/keaa110.005

View record in OpenAIRE

4

Subcutaneous tanezumab 2.5 MG or 5 MG for patients with osteoarthritis of the knee or hip: onset and maintenance of efficacy over 24 weeks

المؤلفون: Lars Viktrup, R. Langford, Francis Berenbaum, Takaharu Yamabe, Naoki Isogawa, Serge Perrot, Rod Junor, Mark T. Brown, Francisco J. Blanco, S. Araki, William Carey, Kenneth M. Verburg, K. Miki, Christine R. West

المصدر: Osteoarthritis and Cartilage. 28:S144-S145

مصطلحات موضوعية: chemistry.chemical_compound, Rheumatology, chemistry, business.industry, Tanezumab, Anesthesia, Biomedical Engineering, Medicine, Orthopedics and Sports Medicine, Osteoarthritis, business, medicine.disease

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::ba8d86d08b5b207ac5ab01a8cb3c7752
https://doi.org/10.1016/j.joca.2020.02.239

View record in OpenAIRE

5

Subcutaneous tanezumab for osteoarthritis of the hip or knee: efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up period

المؤلفون: Mark T. Brown, Rod Junor, Kenji Miki, Francisco J. Blanco, Christine R. West, Francis Berenbaum, Takaharu Yamabe, Kenneth M. Verburg, Ali Guermazi, William Carey, Lars Viktrup

المساهمون: Service de rhumatologie [CHU Saint-Antoine], CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Centre de Recherche Saint-Antoine (CR Saint-Antoine), Sorbonne Université (SU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Saint-Antoine [AP-HP], Boston University School of Medicine (BUSM), Boston University [Boston] (BU), Eli Lilly and Company [Indianapolis]

المصدر: Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2020, 79 (6), pp.800-810. ⟨10.1136/annrheumdis-2019-216296⟩
RUC. Repositorio da Universidade da Coruña
instname
RUC: Repositorio da Universidade da Coruña
Universidade da Coruña (UDC)